Table of Content

1. Executive Summary
   1. Global Immune Checkpoint Inhibitors Market Snapshot, 2025 and 2032
   2. Market Opportunity Assessment, 2025 - 2032, US$ Bn
   3. Key Market Trends
   4. Future Market Projections
   5. Premium Market Insights
   6. Industry Developments and Key Market Events
   7. PMR Analysis and Recommendations
2. Market Overview
   1. Market Scope and Definition
   2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
   3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
   4. COVID-19 Impact Analysis
   5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   1. Product Adoption Analysis
   2. Regulatory Landscape
   3. Value Chain Analysis
   4. Key Deals and Mergers
   5. PESTLE Analysis
   6. Porter’s Five Force Analysis
4. Global Immune Checkpoint Inhibitors Market Outlook:
   1. Key Highlights
      1. Market Size (US$ Bn) and Y-o-Y Growth
      2. Absolute $ Opportunity
   2. Market Size (US$ Bn) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2019-2024
      2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
   3. Global Immune Checkpoint Inhibitors Market Outlook: Drug Type
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Drug Type, 2019 - 2024
      3. Market Size (US$ Bn) Analysis and Forecast, By Drug Type, 2025 - 2032
         1. PD-1 Inhibitor
         2. PD-L1 Inhibitor
         3. CTLA-4 Inhibitor
      4. Market Attractiveness Analysis: By Drug Type
   4. Global Immune Checkpoint Inhibitors Market Outlook: Indication
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Indication, 2019 - 2024
      3. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 - 2032
         1. Non-Small Cell Lung Cancer
         2. Melanoma
         3. Colorectal Cancer
         4. Others
      4. Market Attractiveness Analysis: Indication
   5. Global Immune Checkpoint Inhibitors Market Outlook: Distribution Channel
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2019 - 2024
      3. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
         1. Hospital Pharmacies
         2. Retail Pharmacies
         3. Online Pharmacies
      4. Market Attractiveness Analysis: Distribution Channel
5. Global Immune Checkpoint Inhibitors Market Outlook: Region
   1. Key Highlights
   2. Historical Market Size (US$ Bn) Analysis, By Region, 2019 - 2024
   3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025 - 2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
   4. Market Attractiveness Analysis: Region
6. North America Immune Checkpoint Inhibitors Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Drug Type
      3. By Indication
      4. By Distribution Channel
   3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. U.S.
      2. Canada
   4. Market Size (US$ Bn) Analysis and Forecast, By Drug Type , 2025 - 2032
      1. PD-1 Inhibitor
      2. PD-L1 Inhibitor
      3. CTLA-4 Inhibitor
   5. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Non-Small Cell Lung Cancer
      2. Melanoma
      3. Colorectal Cancer
      4. Others
   6. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
   7. Market Attractiveness Analysis
7. Europe Immune Checkpoint Inhibitors Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Drug Type
      3. By Indication
      4. By Distribution Channel
   3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
   4. Market Size (US$ Bn) Analysis and Forecast, By Drug Type , 2025 - 2032
      1. PD-1 Inhibitor
      2. PD-L1 Inhibitor
      3. CTLA-4 Inhibitor
   5. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Non-Small Cell Lung Cancer
      2. Melanoma
      3. Colorectal Cancer
      4. Others
   6. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
   7. Market Attractiveness Analysis
8. East Asia Immune Checkpoint Inhibitors Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Drug Type
      3. By Indication
      4. By Distribution Channel
   3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. China
      2. Japan
      3. South Korea
   4. Market Size (US$ Bn) Analysis and Forecast, By Drug Type , 2025 - 2032
      1. PD-1 Inhibitor
      2. PD-L1 Inhibitor
      3. CTLA-4 Inhibitor
   5. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Non-Small Cell Lung Cancer
      2. Melanoma
      3. Colorectal Cancer
      4. Others
   6. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
   7. Market Attractiveness Analysis
9. South Asia & Oceania Immune Checkpoint Inhibitors Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Drug Type
      3. By Indication
      4. By Distribution Channel
   3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
   4. Market Size (US$ Bn) Analysis and Forecast, By Drug Type , 2025 - 2032
      1. PD-1 Inhibitor
      2. PD-L1 Inhibitor
      3. CTLA-4 Inhibitor
   5. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Non-Small Cell Lung Cancer
      2. Melanoma
      3. Colorectal Cancer
      4. Others
   6. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
   7. Market Attractiveness Analysis
10. Latin America Immune Checkpoint Inhibitors Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
       1. By Country
       2. By Drug Type
       3. By Indication
       4. By Distribution Channel
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
       1. Brazil
       2. Mexico
       3. Rest of Latin America
    4. Market Size (US$ Bn) Analysis and Forecast, By Drug Type , 2025 - 2032
       1. PD-1 Inhibitor
       2. PD-L1 Inhibitor
       3. CTLA-4 Inhibitor
    5. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 - 2032
       1. Non-Small Cell Lung Cancer
       2. Melanoma
       3. Colorectal Cancer
       4. Others
    6. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
       1. Hospital Pharmacies
       2. Retail Pharmacies
       3. Online Pharmacies
    7. Market Attractiveness Analysis
11. Middle East & Africa Immune Checkpoint Inhibitors Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
       1. By Country
       2. By Drug Type
       3. By Indication
       4. By Distribution Channel
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
       1. GCC Countries
       2. Egypt
       3. South Africa
       4. Northern Africa
       5. Rest of Middle East & Africa
    4. Market Size (US$ Bn) Analysis and Forecast, By Drug Type , 2025 - 2032
       1. PD-1 Inhibitor
       2. PD-L1 Inhibitor
       3. CTLA-4 Inhibitor
    5. Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 - 2032
       1. Non-Small Cell Lung Cancer
       2. Melanoma
       3. Colorectal Cancer
       4. Others
    6. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
       1. Hospital Pharmacies
       2. Retail Pharmacies
       3. Online Pharmacies
    7. Market Attractiveness Analysis
12. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
       1. Competition Intensity Mapping By Market
       2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       1. Sanofi
          1. Overview
          2. Segments and Product
          3. Key Financials
          4. Market Developments
          5. Market Strategy
       2. F. Hoffmann-La Roche Ltd.
       3. Merck & Co.
       4. Bristol-Myers Squibb Company
       5. Regeneron Pharmaceuticals Inc.
       6. AstraZeneca PLC
       7. Shanghai Jhunsi Biosciences Ltd
       8. Immutep.
       9. BeOne Medicines
       10. GSK plc.
       11. HCW Biologics, Inc.
       12. Novocure GmbH
       13. Biond Biologics
       14. Others
13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations